Therapeutic Advances and Evolving Treatment Strategies: Novel Approaches to Migraine Management registration_landing_page
Data suggest that CGRP inhibitors are going to usher in a new era in treatment in migraine.
How will these novel agents affect your practice?

AHS attendees and virtual attendees around the world are invited to join us
Friday, June 9 from 6:30 am - 8:00 am ET
for the complimentary breakfast program.

Therapeutic Advances and Evolving Treatment Strategies:
Novel Approaches to Migraine Management!

Dialogue with experts in this rapidly evolving area and learn what’s happening in clinical trials that may impact your practice in the near future.

Approved for AMA PRA Category 1 Credit

David W. Dodick, MD – Chair
Mayo Clinic
Phoenix, Arizona
Alan M. Rapoport, MD
David Geffen School of Medicine at UCLA
Los Angeles, California
Stewart J. Tepper, MD
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

TWO WAYS TO ATTEND
Live Breakfast Symposium
Westin Boston Waterfront
Web Simulcast
Streamed Live from Boston
REGISTER NOW
LIVE SYMPOSIUM
REGISTER NOW
WEB SIMULCAST

This symposium is a satellite session and not part of the official 59th Annual Scientific Meeting.